NCT03542916

Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers

A Single-blind, Randomized, Single-dose, Crossover Study to Compare the Pharmacokinetics and Safety Following Administration of CJ-40001 and NESP® in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: HK inno.N Corporation · Industry
• Sex: Male
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the pharmacokinetics and safety after a single subcutaneous or intravenous administration of CJ-40001 and NESP® in healthy male volunteers.

Detailed description

The purpose of this study is to compare the pharmacokinetics and safety after a single subcutaneous or intravenous administration of CJ-40001 and NESP in healthy male volunteers.

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DRUG	CJ-40001 60ug	CJ-40001 60ug SC, IV injection
DRUG	NESP 60ug	NESP 60ug SC, IV injection

Timeline

• Start date: 2014-10-01
• Primary completion: 2014-11-01
• Completion: 2015-12-01
• First posted: 2018-05-31
• Last updated: 2018-05-31

Locations

1 site across 1 country: South Korea